U.S., Oct. 29 -- An application to own the trademark for 'ZYAMTIN' has been filed on May. 08, 2025.
Owner(s):
uniQure biopharma B.V.; Paasheuvelweg 25, , NETHERLANDS
Goods and/or Services:
For: Biological preparations for medical use in medical and clinical gene therapy and cell therapy; clinical medical reagents for use in gene therapy, gene diagnosis, and gene testing; pharmaceutical preparations, namely, vaccines for use in gene therapy; pharmaceutical preparations for the treatment of Dravet's disease, Alzheimer's disease, ALS, Huntington's disease, Fragile X syndrome, Parkinson's disease, A1AT deficiency, epilepsy, temporal lobe epilepsy, focal cortical dysplasia, Fabry disease, multiple system atrophy, spinocerebellar ataxia an...